198 related articles for article (PubMed ID: 11383751)
1. Pharmacoeconomics of hypertension management: the place of combination therapy.
Ambrosioni E
Pharmacoeconomics; 2001; 19(4):337-47. PubMed ID: 11383751
[TBL] [Abstract][Full Text] [Related]
2. Healthcare benefits of very-low-dose combination treatment used in the management of hypertension.
Ambrosioni E
J Hypertens Suppl; 2001 Nov; 19(4):S29-36. PubMed ID: 11848260
[TBL] [Abstract][Full Text] [Related]
3. Pharmacoeconomic challenges in disease management of hypertension.
Ambrosioni E
J Hypertens Suppl; 2001 Sep; 19(3):S33-40. PubMed ID: 11713849
[TBL] [Abstract][Full Text] [Related]
4. Pharmacoeconomics of hypertension control: basic principles of economic evaluation.
Wilson TW; Chockalingam A; Quest DW
J Hum Hypertens; 1996 Feb; 10 Suppl 2():S19-22. PubMed ID: 8868039
[TBL] [Abstract][Full Text] [Related]
5. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
6. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
7. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
Thomas GN; Chan P; Tomlinson B
Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacoeconomic analysis of antihypertensive therapy: advantages of fixed combinations].
Leonova MV; Erofeeva SB; Bykov AV; Belousov IuB
Kardiologiia; 2008; 48(1):43-50. PubMed ID: 18260995
[No Abstract] [Full Text] [Related]
9. The future of antihypertensive treatment.
Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
[TBL] [Abstract][Full Text] [Related]
10. Pharmacoeconomic considerations in the management of hypertension.
Pardell H; Tresserras R; Armario P; Hernández del Rey R
Drugs; 2000; 59 Suppl 2():13-20; discussion 39-40. PubMed ID: 10678593
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacoeconomic assessment of antihypertensive therapy for patients of elderly and senile age in the hospital for veterans of war].
Hrinenko IuO; Kuprash LP
Lik Sprava; 2010; (3-4):108-16. PubMed ID: 21265129
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of irbesartan/hydrochlorothiazide in patients with hypertension: an economic evaluation for Sweden.
Ekman M; Bienfait-Beuzon C; Jackson J
J Hum Hypertens; 2008 Dec; 22(12):845-55. PubMed ID: 18633426
[TBL] [Abstract][Full Text] [Related]
13. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
[TBL] [Abstract][Full Text] [Related]
14. [Pharmaco-economic aspects of the treatment of hypertension].
Delporte JP; Rorive G
Rev Med Liege; 1998 May; 53(5):259-64. PubMed ID: 9689879
[TBL] [Abstract][Full Text] [Related]
15. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive treatment with and without benazepril in patients with chronic renal insufficiency: a US economic evaluation.
Hogan TJ; Elliott WJ; Seto AH; Bakris GL
Pharmacoeconomics; 2002; 20(1):37-47. PubMed ID: 11817991
[TBL] [Abstract][Full Text] [Related]
17. Using fixed-dose combination therapies to achieve blood pressure goals.
Chrysant SG
Clin Drug Investig; 2008; 28(11):713-34. PubMed ID: 18840014
[TBL] [Abstract][Full Text] [Related]
18. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS
JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325
[TBL] [Abstract][Full Text] [Related]
19. Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy.
Dickson M; Plauschinat CA
Am J Cardiovasc Drugs; 2008; 8(1):45-50. PubMed ID: 18303937
[TBL] [Abstract][Full Text] [Related]
20. Management Practices in Indian Patients with Uncontrolled Hypertension.
Bharatia R; Chitale M; Saxena GN; Kumar RG; Chikkalingaiah ; Trailokya A; Dalvi K; Talele S
J Assoc Physicians India; 2016 Jul; 64(7):14-21. PubMed ID: 27759337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
